Search

everythinglearnresearchcommunity

for

Search:↓

Possible link between COVID-19 and hair loss; more research needed.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Some cases of folliculotropic mycosis fungoides may progress slowly and not need aggressive treatment.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Two rare bald spots on the back of the scalp were found to be lupus, not alopecia areata.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

Dr. Robert S. Haber concluded that hair transplant surgeons must master scalp biopsy techniques to quickly diagnose and treat hair loss conditions.

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

A 66-year-old woman's thick scalp and hair loss were confirmed as lipedematous alopecia, a rare condition possibly influenced by genetics, with no effective treatment known.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

EVG staining is a valuable, simple, and cost-effective method for diagnosing various skin conditions in dermatopathology.

The patient has frontal fibrosing alopecia (FFA).

Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.